Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Y Humblet"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D Leonard, F Penninckx, A Kartheuser, A Laenen, E Van Eycken, C Bertrand, D De Coninck, M Duinslaeger, J Van de Stadt, W Vaneerdeweg, D Claeys, D Burnon, K Haustermans, P Scalliet, P Spaas, P Demetter, A Jouret-Mourin, C Sempoux, W Demey, Y Humblet, E Van Cutsem, S Laurent, J L Van Laethem, B Op de Beeck, P Smeets, M Melange, J Rahier, M Cabooter, P Pattyn, M Peeters, M Buset, B Mansvelt, K Vindevoghel, M Daubie, A Thijs
Publikováno v:
The British journal of surgery, Vol. 101, no. 11, p. 1475-82 (2014)
Background Research on the relationship between hospital volume and quality of care in the treatment of rectal cancer is limited. Methods Process and outcome indicators were assessed in patients with rectal adenocarcinoma who underwent total mesorect
Autor:
A. Johnston, C. Domenge, N. Clendeninn, S. Wadler, C. Penning, Y. Humblet, D. Belpomme, C. Kelly, J. Stern, J. Tortochaux, X. Pivot, M. Schneider, R. Ruxer
Publikováno v:
Annals of Oncology. 12:1595-1599
We report on two randomized trials performed in the USA and Europe, which compared methotrexate and nolatrexed as treatment for patients with recurrent head and neck cancer. Eligibility criteria included: histologically confirmed squamous-cell carcin
Autor:
G.F. Kao, A. Alomar, J. Forn, B. Boyden, J.-H. Saurat, T. Tsuchida, S. Dhar, W.J. Cunliffe, M.F. Larmuseau, N.P. Smith, N. Poesen, U. Sass, H.I. Joller-Jemelka, G.P.H. Lucker, P. Hall-Smith, V. Madoe, F.O. Nestle, P. Bruderer, P. Chavaz, P. De Doncker, F. Sente, M.T. Dours-Zimmermann, Y. Humblet, V. Goulden, P.M. Steijlen, W. Broeckx, T. Watanabe, J. Delgadillo, P. Van Dam, M. Shahabpour, S.C. Murphy, A.J. Kanwar, S. Vossough, B.J. Nickoloff, C. Stenier, K. Holubar, G.E. Piérard, P.C.M. van de Kerkhof, J.R.M. Cruysberg, R. Dummer, L. Bossuyt, R.O. Leder, M. Tanaka, M. Wyss, M. Ledoux, M.H. Lowitt, B. Dezfoulian, S. Christoffersen, J.J. Van den Oord, S.N. Dommann, S. Videla, A.M. Layton, B.A. Gilchrest, H. Degreef, H. Tagami, A.F. Nikkels, V. Meuleman, I. Gich, J. André, M. Pechère, N. Nikkels-Tassoudji, M. Garmyn, C. Piérard-Franchimont, D.J. der Kinderen, M. Morren, H. Aoyama, M. Heidbüchel, A. Bourlond, J.E. Arrese, G. Burg, N. Matsumura, F. Gilliet, M. Bamelis, V.A. Hill, R. Roelandts, D.I. Wilkinson, S. Aiba, I. Izquierdo, H. Weltman
Publikováno v:
Dermatology. 190:I-VI
Autor:
H, Bleiberg, A, Vandebroek, I, Deleu, P, Vergauwe, H, Rezaei Kalantari, G, D'Haens, M, Paesmans, M, Peeters, A, Efira, Y, Humblet
Publikováno v:
Acta gastro-enterologica Belgica. 75(1)
Leucovorin Sodium (LV/Na) has a high solubility, and is stable when given with continuous infusion of 5-FU. It could maintain significant plasma concentration of 5, 10-meTHF during the whole 5-FU perfusion with the potential of increasing 5-FU cytoto
Publikováno v:
JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR). 91(4)
Publikováno v:
European Respiratory Journal. 3:699-714
Despite disappointing results in the treatment of small cell lung cancer (SCLC), major progress in our understanding of SCLC biology has occurred in the past decade. Advances in the technique for culturing SCLC tumours in vitro have greatly facilitat
Publikováno v:
Dermatology. 190:332-334
A 63-year-old woman presented with a large, subumbilical ulcerated nodule that was a Ki-1+ anaplastic large-cell lymphoma with exclusively cutaneous localization. This high-grade lymphoma, in this case, has a less severe prognosis. Surgical resection
Publikováno v:
JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR). 86(2)
Publikováno v:
Acta gastro-enterologica Belgica. 64(4)
Gemzar is a nucleoside analog that has been shown to be superior to 5-fluorouracil for the treatment of advanced pancreatic cancer in terms of both clinical benefit and survival. This open label program enrolled 214 patients. Patients eligible for th